Case Report

Community-Acquired Methicillin Resistant Staphylococcus aureus in a Women’s Collegiate Basketball Team

Authors: Michael P. Stevens, MD, Gonzalo Bearman, MD, MPH, Adriana Rosato, PhD, Michael Edmond, MD, MPH, MPA


Community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) infections are becoming increasingly frequent, and cutaneous disease with this organism is often seen in otherwise healthy organized sports participants. A case of CA-MRSA skin and soft tissue infection in a female collegiate basketball player is presented, and screening and management of her team is discussed. Interestingly, multiple MRSA strains were discovered on testing of the team, raising concern that the prevalence of colonization in this population may be high.

Key Points

* Community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) must be considered in any athlete presenting with a skin or soft tissue infection.

* The discovery of a CA-MRSA skin and soft tissue infection in an athlete has implications for the surveillance and management of other potentially exposed athletes.

* The discovery of multiple different MRSA isolates on team surveillance may indicate a higher than expected prevalence of colonization in this population.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Cohen PR. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. South Med J 2005;98:596–602.
2. Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007;13:222–235.
3. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control 2006;34(5 suppl 1):S11–S19; discussion S64–S73.
4. Rihn JA, Michaels MG, Harner CD. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging problem in the athletic population. Am J Sports Med 2005;33:1924–1929.
5. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044–4048.
6. Sedgwick PE, Dexter WW, Smith CT. Bacterial dermatoses in sports. Clin Sports Med 2007;26:383–396.
7. Brinsley-Rainisch KJ, Goding AM, Cochran RL, et al. MRSA infections in athletics: perceptions and practices of certified athletic trainers. In: Abstracts of the 17th Annual Society for Healthcare Epidemiology of America’s Annual Scientific Meeting, Baltimore, MD, April 14–17, 2007. Alexandria, VA, Society for Healthcare Epidemiology of America, 2007, Abstract 70.